NAMI - National Alliance on Mental Illness Home | About NAMI | Contact Us | En Espanol  | Donate  
Find
  Advanced Search  
 

Sign In
myNAMI
Communities
Register and Join
Donate
What's New
State & Local NAMIs
Advocate Magazine
NAMI Newsroom
NAMI Store
NAMIWALKS
National Convention
Special Needs Estate Planning
NAMI Travel

  Make a Donation
 Issues Spotlights
  Access to Medications
  Children
  Confidentiality
  Criminalization
  Death Penalty
  Employment
  Health Reform
  Housing
  Managed Care
  Medicaid
  Medicare
  Parity
  Prescribing Privileges for Psychologists
  Psychiatric Advance Directives
  Research
  Seclusion and Restraints
  SSI/SSDI
  State and Federal Budget Issues
  Veterans
  Uninsured
  DSM5
  Hill Day
  Homelessness
  Elections

Print this page
Graphic Site
Log Out
 | Print this page | 
 | 

Oregon’s Center for Evidence-Based Practice Program

The Center for Evidence-based Practice (Center) is directed by former Oregon Governor John Kitzhaber. It is a collaboration between the Oregon Health Sciences University (OHSU), which contracts with three Evidence-based Centers (designated by the federal Agency for Health Care Research and Quality) at UCLA, UNC and OHSU for review of existing studies comparing drugs within a therapeutic class. The Center states that its purpose is to "promote collaboration among citizens, non-profit organizations, business, labor, research and government entities" on policy solutions.

The first project of the Center is the "Drug Effectiveness Review Project", which aims to conduct wide-ranging reviews of all available research on classes of medications and determine the "best" therapies in those classes based on the evidence from clinical studies, journaled comparative analyses and even manufacturer dossiers. However, the group's literature also notes that when studies are inconclusive about obvious "best choice" among therapies in a class, the cheapest option will be favored for a preferred drug list.

The Center is approaching Medicaid agencies in reportedly over a dozen states who, for $100,000 (which has to come from State General Fund dollars), will gain access to this scientific review of evidence and obtain guidance regarding which medications have an "evidence base" to be included in preferred drug lists (PDLs).

The Center has not done any evaluation of mental health medication classes to date; however, draft recommendations for antidepressants (SSRIs) may be submitted to independent reviewers by the end of May 2004.

NAMI advocates are asked to monitor closely potential initiatives in their state Medicaid programs that would incorporate the Center’s recommendations. If the state Medicaid program is holding discussions with the Center, please use the issues highlighted in the letter that NAMI sent to the Center, to express your affiliate’s concerns directly to Medicaid officials in your state. Click here to read the letter.


 | Print this page | 
 | 

Donate

Support NAMI to help millions of Americans who face mental illness every day.

Donate today

Speak Out

Inspire others with your message of hope. Show others they are not alone.

Share your story

Get Involved

Become an advocate. Register on NAMI.org to keep up with NAMI news and events.

Join NAMI Today
Home  |  myNAMI  |  About NAMI  |  Contact Us  |  Jobs  |  SiteMap

Copyright © 1996 - 2011 NAMI. All Rights Reserved.